

PackagingIn a bottle of dark glass 50 capsules. In the package 1 bottle. Mechanism of actionErmital contains standard highly active Pancreatin, obtained from the pancreas of the pig in the form of microtablets resistant to the effects of gastric juice. The drug compensates for the deficiency of pancreatic enzymes, has a proteolytic, amylolytic and lipolytic action.Its enzymes (lipase, alpha-amylase, trypsin, chymotrypsin) promote the breakdown of proteins to amino acids, fats - to glycerol and fatty acids, starch - to dextrins and monosaccharides, improves the functional state of the gastrointestinal tract, normalizes digestion. Indications and usage- To improve the digestion of food in patients with normal function of the gastrointestinal tract in case of errors in nutrition. | Contraindications - Known hypersensitivity to pancreatic enzymes. Do not use during pregnancy. During breastfeeding, the risk / benefit ratio must be considered. Dosage and administrationInside Doses are selected individually depending on the severity of the disease and diet. Adverse reactionsAllergic reactions of immediate type (urticaria, lacrimation, runny nose, bronchospasm). Irritation of the gastrointestinal mucosa, as well as in the anus.Rarely: diarrhea or constipation, nausea, epigastric discomfort. With prolonged use in high doses - hyperuricuria. With prolonged use in high doses in patients with cystic fibrosis - strictures in the ileo-cekal department and in the ascending colon. Special notesWhen taken in high doses, unusual symptoms and side effects from the gastrointestinal organs should be carefully controlled. With prolonged use with cystic fibrosis may develop constipation, strictures of the ileum and cecum, colitis. Drug InteractionsWhen taking the drug Ermital may decrease the absorption of folic acid. Ermital reduces iron absorption. During the treatment with Ermital, it is possible to reduce the effectiveness of hypoglycemic agents for oral administration - acarbose and miglitol. OverdosageSymptoms: hyperuricuria, hyperuricemia. Storage conditionsThe drug should be stored out of reach of children at a temperature not exceeding 25 ° C. |